FDA Clearance Tracker · P970003-S170
VNS THERAPY SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 12, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Feb 12, 2016
Approved
Time to decision
655 days
Received Apr 28, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P970003-S170
- Device name
- VNS THERAPY SYSTEM
- Applicant
- LivaNova USA, Inc.
- Applicant location
- Houston, TX
- Received
- Apr 28, 2014
- Decided
- Feb 12, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P970003
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Cyberonics Latam S.L.R., Edificio B49, 51 Ave 0, Zona Franca Coyol, Coyol - Alajuela, Costa Rica facility, in which the site will perform the final assembly, packaging, storing, and distribution of the Implantable Pulse Generators and the Lead Finals.
Source documents
Other decisions for LivaNova USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250013 · Decided Mar 18, 2026 · 327 days after receipt
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.